Core Viewpoint - On January 16, two listed companies had their restricted shares unlocked, with a total market value of approximately 52.07 million yuan [1] Group 1: Company Specifics - Company: Three Gorges Energy (Stock Code: 600905) - Type of Restricted Shares: Equity Incentive Restricted Circulation - Number of Unlocked Shares: 1.8963 million [1] - Company: Chengdi Xiangjiang (Stock Code: 603887) - Type of Restricted Shares: Equity Incentive Restricted Circulation - Number of Unlocked Shares: 6.8325 million [1]

Group 1 - The company has repaid a total of RMB 190 million of temporarily used idle raised funds as of January 13, 2026 [1][2][3] - The board of directors and the supervisory board approved the use of RMB 190 million of idle raised funds for temporary working capital on January 15, 2025, with a usage period not exceeding 12 months [1] - The company has returned the RMB 190 million to its special account for raised funds and notified the sponsor institution and representative in a timely manner [3]

证券代码：603887 证券简称：城地香江 公告编号：2026-003 | 发行名称 | 2020年公开发行可转债 | | --- | --- | | 募集资金到账时间 | 2020年8月3日 | | 临时补流募集资金金额（万元） | 19,000 | | --- | --- | | 补流期限 | 2025-01-15至2026-01-14 | 二、归还募集资金的相关情况 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 截至 2026 年 1 月 13 日，公司已累计归还临时补充流动资金的闲置募 集资金人民币 19,000 万元。 一、募集资金临时补充流动资金情况 上海城地香江数据科技股份有限公司（以下简称"公司"）于2025年1月15日 召开第五届董事会第十三次会议和第五届监事会第九次会议，分别全票审议通过 了《关于使用部分闲置募集资金临时补充流动资金的议案》，同意公司使用部分 闲置募集资金19,000万元临时补充公司流动资金，使用期限为自董事会审议通过 之日起不超过12个月，详见2025年1月16日公司在上 ...

Group 1: Central Bank and Economic Policies - The People's Bank of China has increased its gold reserves for the 14th consecutive month, reaching 74.15 million ounces (approximately 2306.323 tons), with a month-on-month increase of 30,000 ounces (about 0.93 tons) [1] - The Ministry of Industry and Information Technology and eight other departments have issued an implementation opinion to promote the development of intelligent chips, focusing on key technologies such as high-end training chips and AI servers [1] - Multiple departments held a meeting to discuss the battery industry, aiming to regulate competition and promote high-quality development in the lithium battery sector [1] Group 2: Pharmaceutical and Regulatory Updates - The National Medical Products Administration has optimized the review and approval process for urgently needed overseas drugs to meet clinical demands, encouraging simultaneous R&D and application in China [2] - The Ministry of Commerce has initiated an anti-dumping investigation into imported dichlorodihydrosilane from Japan, with the investigation period set from July 1, 2024, to June 30, 2025 [2] Group 3: Company-Specific Developments - Guanglian Aviation plans to acquire a stake in Tianjin Yuefeng to engage in the R&D and manufacturing of core components for commercial rockets, with significant revenue contributions from national tasks [3] - Shenzhen Yihong Technology has received a regulatory warning from the Shanghai Stock Exchange for misleading disclosures regarding its strategic cooperation with Brain Machine Starlink Technology [4] - Shenzhen Yingjixin Technology has also received a regulatory warning for inaccurate disclosures about its brain-computer interface chip, which is still in the market cultivation phase [6] - Fenglong Co. has announced that it may apply for a trading suspension if its stock price continues to rise abnormally, following a significant increase in its stock price over recent trading days [7] - Chengdi Xiangjiang has reported a projected revenue decrease of approximately 1.092 billion yuan due to changes in the investment conditions of a data center project [7] - Zhenxin Technology's subsidiary has been banned from participating in procurement activities in the Western Theater for three years due to collusion in bidding [9] - Koushijiao has projected a 50%-60% decrease in net profit for 2025, primarily due to a significant drop in sales of high-end products [10] - Heng Rui Medicine has received approval for its innovative drug, which is the first of its kind to be approved for market use [11] - Nanjing Panda has clarified that it currently has no mature products related to brain-computer interfaces and has not generated related sales revenue [11] - Guangqi Technology has signed contracts worth a total of 264 million yuan for the mass production of metamaterials [11] - Zhongke Lanyun expects a net profit increase of 367%-377% for 2025, driven by significant gains from investments in other companies [12] - Pulit has developed LCP film technology for brain-computer interfaces and is collaborating with overseas clients for product development [13]

Group 1 - The Ministry of Industry and Information Technology and seven other departments issued the "Implementation Opinions on the Special Action of 'Artificial Intelligence + Manufacturing'", aiming to promote the deep application of 3-5 general large models in manufacturing by 2027, create 100 high-quality data sets in industrial fields, and establish 500 typical application scenarios [1][1][1] - The People's Bank of China reported that the gold reserves at the end of December reached 74.15 million ounces (approximately 2306.323 tons), an increase of 30,000 ounces (about 0.93 tons) month-on-month, marking the 14th consecutive month of gold accumulation [1][1][1] - The Ministry of Industry and Information Technology released the "Action Plan for the Integration of Industrial Internet and Artificial Intelligence", which aims to expand the scale of new industrial networks that meet the high throughput, low latency, high reliability, and low jitter communication needs by 2028, with a target of implementing new industrial network upgrades in no less than 50,000 enterprises [1][1][1] Group 2 - The Ministry of Commerce announced an anti-dumping investigation on imported dichlorodihydrosilane from Japan, with the investigation period set from July 1, 2024, to June 30, 2025, and the industry damage investigation period from January 1, 2022, to June 30, 2025 [1][1][1] - The Shanghai Futures Exchange adjusted the price limit for silver futures contracts AG2601, AG2602, AG2603, and AG2604 to 16%, with the margin ratio for maintaining positions set at 17% and for general positions at 18% [1][1][1] - Multiple departments held a symposium on the power and energy storage battery industry, focusing on controlling production capacity, managing price wars, and protecting patents to address industry "involution" [1][1][1] Group 3 - China Ping An Life Insurance Company announced that Ping An Asset Management, entrusted with Ping An Life's funds, will invest in Agricultural Bank of China H-shares, reaching 20% of the bank's equity by December 30, 2025, triggering a mandatory disclosure under Hong Kong market rules [1][1][1] - Liyang Chip responded to rising storage prices, indicating that some product lines are experiencing tight testing capacity, leading some customers to request price increases to secure output [1][1][1] - Guanglian Aviation announced that Tianjin Yuefeng, as a core supplier for Tianbing Technology's Tianlong No. 3, will undertake the manufacturing tasks for the entire rocket storage tank and some structural components [1][1][1] Group 4 - Heng Rui Medicine announced that its innovative Class 1 drug, Rilafurpu α injection, has been approved for market launch, with no similar products approved domestically or internationally [1][1][1] - The announcement from *ST Sunshine indicated that the controlling shareholder is planning a change of control, leading to a suspension of trading [1][1][1] - The three consecutive board announcements from Pulit indicated that LCP film technology has a high barrier to entry and is the only company in China to achieve breakthroughs in this technology, collaborating with overseas clients on applications in brain-computer interfaces [1][1][1]

Core Viewpoint - The company announced significant changes in the "Yangzhou Computing Center Project" with China Mobile, leading to a reduction in expected revenue by approximately 1.09 billion yuan due to the client taking over the construction of two data center buildings [1][2]. Group 1: Project Updates - The company has completed and is operating buildings B01 to B03 of the Yangzhou Computing Center Project, while buildings B04 and B05 will now be constructed by China Mobile, resulting in a loss of expected revenue of about 1.09 billion yuan [1]. - The company will no longer have obligations under the original contract for B04 and B05, which will also significantly reduce the required capital investment and bank liabilities for the project [1]. Group 2: Financial Performance - For the first three quarters of 2025, the company reported total revenue of 1.714 billion yuan, a year-on-year increase of 106.96%, and a net profit attributable to shareholders of 2.853 million yuan, marking a turnaround from previous losses [3]. - The company has experienced a decline in revenue over the past four years, with reported revenues of 2.907 billion yuan in 2021, 2.684 billion yuan in 2022, 2.433 billion yuan in 2023, and 1.621 billion yuan in 2024, indicating a continuous downward trend [4]. Group 3: Regulatory Issues - The company received a warning from the Shanghai Securities Regulatory Bureau due to discrepancies in seven financial reports, including errors in internal transaction offsets and revenue recognition [5]. - The regulatory actions included warnings to the company's chairman and financial directors, highlighting the need for improved financial reporting practices [5].

分组1 - Heng Rui Medicine's innovative drug Ruilafup α injection has been approved for market launch, with no similar products approved domestically or internationally [1] - The drug is used in combination with fluorouracil and platinum-based drugs for first-line treatment of locally advanced unresectable, recurrent, or metastatic gastric and gastroesophageal junction adenocarcinoma with confirmed PD-L1 positivity (CPS≥1) [1] - The total R&D investment for Ruilafup α injection has reached approximately 711 million yuan [1] 分组2 - Cheng Jian Development reported that its investment in Century Space is currently in a loss state, with no unrecognized revenue impacting its operations [2] - Zhongke Lanyun expects a significant net profit increase of 366.51% to 376.51% for 2025, driven by substantial fair value changes from investments in Moer Thread and Muxi Co., Ltd [2] 分组3 - Nanjing Panda stated that it currently has no mature products related to brain-computer interfaces and has not generated related sales revenue [3] - Kecuan Technology's subsidiary has established optical module production capacity, and silicon photonic chips have completed their first tape-out but have not yet generated revenue [3] 分组4 - Zhuhai Ming Technology's subsidiary has been allocated 66,900 H-shares of Zhihua, amounting to 7.7738 million Hong Kong dollars [4] - Chengdi Xiangjiang announced that the revenue from the construction of two data center buildings will decrease by approximately 1.092 billion yuan due to changes in business conditions [4]

Company Announcements - Vice Chairman Meng Xue of Xin Hong Ze voluntarily waived his salary to support the company's long-term development, effective from January 2026 [2] - Feng Long Co. announced a potential suspension of trading if its stock price continues to rise abnormally, following an 8-day trading limit increase of over 100% [2] - Zhenxin Technology's subsidiary was banned from participating in procurement activities in the Western Theater for three years due to collusion in bidding [3] - ST Sunshine's controlling shareholder is planning a change in control, leading to a temporary suspension of trading [4] - Zhuhai Ming Technology's subsidiary acquired 66,900 shares of H-shares from Zhipu for HKD 777,380 [5] - Siquan New Materials' fourth-largest shareholder plans to reduce his stake by up to 1.79% [6] Financial Performance - Kouzi Jiao expects a 50%-60% decline in net profit for 2025, primarily due to a significant drop in sales of high-end products [7] - CIMC Group anticipates a reduction of approximately CNY 1.1 billion in net profit due to the sale of properties [7] - Zhongke Lanyun forecasts a net profit increase of 367%-377% for 2025, driven by significant gains from investments [26] - Chuan Jin Nuo expects a net profit increase of 144%-173% for 2025, attributed to strong market demand and improved production efficiency [11] - Qian Yang Qian predicts a net profit increase of 147.89% for 2025, supported by a rise in sales volume [28] Contracts and Projects - Guangqi Technology's subsidiary signed contracts totaling CNY 264 million for the production of metamaterials [33] - Diti Design's subsidiary signed a contract worth approximately CNY 311 million for comprehensive energy management services [34] Shareholder Actions - Several companies, including Tuo Jing Technology and North Navigation, announced plans for share reductions by major shareholders [20][10] - Yili's chairman plans to reduce his stake by up to 0.98% to repay stock pledge financing [13] Other Developments - Heng Rui Pharmaceutical's innovative drug received approval for market launch, with no similar products approved domestically or internationally [39] - Xin Li Tai's innovative drug clinical trial application was accepted, targeting a significant health issue [38]

Group 1 - North Navigation announced that it has no relevant business in the commercial aerospace sector and has not obtained any related orders [1][2] - Su Mei Da plans to acquire 16.92% of Blue Science and Technology shares for a total price of 403 million yuan [6] - Shenling Environment intends to invest 50 million yuan in an industrial investment fund focusing on data centers, hard technology, AI, and renewable energy [3] Group 2 - Zhaoming Technology's subsidiary received allocation of 66,900 shares from Zhiyu, amounting to 7.7738 million Hong Kong dollars [4] - Anke Intelligent Electric won a contract worth approximately 75.79 million yuan for an EPC project with a Pakistani power company [10] - The company Huizhong shares renewed a strategic cooperation agreement with Anfu Li to enhance global market sales and joint product development [11] Group 3 - The company Wanglong New Energy plans to sell 100% of its subsidiary Dujianglong Energy for 197 million yuan [11] - Xiangyang Bearing announced a free transfer of state-owned shares, which will not significantly impact its operations [12] - The company Sanhua Intelligent Control announced a cash dividend of 1.20 yuan per 10 shares for its A-share holders [13] Group 4 - The company Zhiwei Technology expects a net profit decrease of 50% to 60% for 2025, primarily due to market changes in the liquor industry [18] - The company Dongrui shares reported a 43.07% increase in pig sales revenue for 2025 [19] - The company Lihua shares reported a total sales revenue of 14.26 billion yuan from meat chickens in 2025 [20] Group 5 - The company Jiyou shares expects a net profit loss for 2025 due to market demand issues [21] - The company Zhongke Blue News anticipates a net profit increase of 366.51% to 376.51% for 2025, driven by investments in certain companies [22] - The company Chuanjinno expects a net profit increase of 144.24% to 172.64% for 2025 due to market demand and production optimization [23]

Core Viewpoint - The company announced a significant change in the business conditions of the B04-B05 data center project, resulting in a reduction of expected revenue by approximately 1.09 billion yuan, while also decreasing future capital investment and operational risks [1][2]. Group 1: Project Changes - The B04-B05 data center buildings will now be constructed by China Mobile, and the company will no longer fulfill its contractual obligations for these buildings, leading to a revenue decrease of about 1.09 billion yuan [1]. - The company has completed the delivery of the B01-B03 buildings, meeting a total IT resource service demand of 84MW, generating revenue of 102 million yuan since delivery, with an expected additional revenue of approximately 2.01 billion yuan over the next ten years [2]. Group 2: Strategic Transition - The company has successfully transitioned from traditional infrastructure to new infrastructure, focusing on IDC/AIDC-related businesses, and has been delivering projects on time, including several significant data center projects [3]. - The company anticipates achieving a revenue of 1.714 billion yuan in the first three quarters of 2025, representing a year-on-year increase of 106.96%, and has turned a profit with a net income of 2.853 million yuan [3].